Types of diseases treated with midostaurin and medication guide

Midostaurin, a highly anticipated antineoplastic drug, has shown significant efficacy in the treatment of certain leukemias and mastocytosis. By effectively inhibiting the proliferation of tumor cells, it provides new treatment strategies for patients with these diseases. Next, we will introduce in detail the main treatment targets of midostaurin and its correct use.

1. Treatment scope

1. FLT3Mutation-positive acute myeloid leukemia(AML): midostaurin and standard chemotherapy drugs (such as cytarabine Used in combination with daunorubicin), it is specifically used to treat adult patients with newly diagnosed AML mutation-positive FLT3 mutations.

2. Systemic mastocytosis: Applicable to adult patients with aggressive systemic mastocytosis(ASM), systemic mastocytosis associated with blood tumors(SM-AHN), and mast cell leukemia(MCL).

2. Medication Guide

1. Prerequisite: Before using midostaurin, it must be diagnosed by a professional doctor in the hospital and ensure that the patient meets the indications for the medication.

2. Medication dosage and frequency:

1) For FLT3 mutation-positive AML, it is recommended to take 50 mg twice daily, combined with chemotherapy drugs, on days 8-21 of each induction and each consolidation treatment cycle.

2) For ASM, SM-AHN and MCL, 100mg twice daily is recommended.

3. How to use: Midostaurin is an oral capsule and should be taken with food to increase the absorption rate. Note that the capsule must not be broken and must be taken whole.

4. Adverse reaction management: If you encounter serious adverse reactions, such as lung problems, nausea, vomiting, etc., you need to seek medical treatment in time, and the dose may need to be adjusted or the medication may be suspended.

5. Continuous monitoring: During treatment, patients should receive regular medical examinations and evaluations to ensure the effectiveness and safety of the treatment.

In summary, midostaurin provides new therapeutic opportunities for patients with FLT3 mutation-positive AML and systemic mastocytosis. However, when using it, you must strictly follow the doctor's instructions and pay attention to the dosage and usage of the drug to ensure the safety and effectiveness of the treatment. Regarding price considerations, the current price of the Indian version of midostaurin is relatively affordable, but you must go through formal channels when purchasing.